Sanofi recalls Zantac in the U.S. and Canada
BRIDGEWATER, N.J.— Sanofi announced on Friday that it was recalling the over-the-counter heartburn drug Zantac in the United States and Canada, a month after the Food and Drug Administration first alerted the public that versions of the drug contained low levels of a cancer-causing contaminant. Several manufacturers of generic versions of Zantac, ranitidine, had already recalled their
